the aid library

LIST OPTIONS

Filter

851

Download (155)

View PDF (193)

Questions prioritaires de recherche sur la co-infection tuberculose/VIH dans les pays prévalents pour le VIH et disposant de ressources limitées

H, Getahun; R. Granich; C. Lienhardt; et al. Organisation Mondiale de la Santé (TBHIV Working Group) (2010) C_WHO

Stop TB Partnership

Download (1761)

View PDF (1859)

WHO guidance: Public health response to biological and chemical weapons

World Health Organization (2004) C_WHO

The message contained in this publication is clear: countries need a public health system that can respond to the deliberate release of chemical and biological agents. Regrettable though this message may be, the use of poison gas in the war between Iraq and the Islamic Republic of Iran in the 19... more

Download (1946)

View PDF (2014)

Second-Line Antituberculosis Drugs in Children: A Commissioned Review for the World Health Organization 19th Expert Committee on the Selection and Use of Essential Medicines

Malgosia Grzemska, Elizabeth Mathai World Health Organization WHO (2013)

External Link

Out of the dark: Meeting the needs of children with TB

Médecins sans Frontières (2011) C3

Download (240)

View PDF (310)

World Report on Vision

World Health Organization WHO (2019) C_WHO

At present at least 2.2 billion people around the world have a vision impairment, of whom at least 1 billion have a vision impairment that could have been prevented or is yet to be addressed. The world faces considerable challenges in terms of eye care, including inequalities in the coverage and qua... more

Download (553)

View PDF (397)

Management of Diabetes Mellitus-Tuberculosis
recommended

Lin, Y., et al. The Union (2019) C1

1st edition This resource provides practical guidance for front line health workers responsible for the diagnosis, management and care of patients with these two diseases. Published in collaboration with the World Diabetes Foundation

Download (230)

View PDF (315)

One health joint plan of action (‎2022‒2026)‎: working together for the health of humans, animals, plants and the environment
recommended

World Health Organization WHO (2022) C_WHO

The Quadripartite Organizations – the Food and Agriculture Organization of the United Nations (FAO), the United Nations Environment Programme (UNEP), the World Organisation for Animal Health (WOAH, founded as OIE), and the World Health Organization (WHO) – collaborate to drive the change and tra... more

Download (994)

View PDF (394)

Indonesia Health Profile 2015 (Part 2/2)

Ministry of Health Republic of Indonesia (2016) C1

Download (623)

View PDF (837)

National Guidelines for HIV and AIDS Treatment and Care in Adolescents and Adults

Federal Ministry of Health Nigeria , World Health Organisation (WHO) (2010) C_WHO

Download (328)

View PDF (304)

App for its Medical Eligibility Criteria for Contraceptive Use

Johns Hopkins Bloomberg School of Public HealthCenter for Communication Programs and World Health Organization (2022) C_WHO

Recommendations on the initiation and continuing use of nine common types of contraceptive methods are covered by the tool. In addition to looking at individual medical conditions or characteristics, users may also easily combine multiple conditions or characteristics and view the guidance on each c... more

Download (219)

View PDF (213)

L'Afrique face à la pandémie de la COVID-19

Bapoutou, B.; et al. Jésuites d'Afrique de l'Ouest (2020) CC

IBOGA Review No.1 Revue Scientifique du Jésuites d'Afrique de l'Ouest

Download (75)

View PDF (85)

Epidemiology and Challenges of Managing COPD in sub-Saharan Africa

Magitta, N.F.; Sciences, A. Acta Scientific Medical Sciences (2018) CC2

There is paucity of data on the burden and specific drivers operative in the pathogenesis of chronic obstructive pulmonary disease (COPD) in the African setting and populations. Lack of awareness and inadequate knowledge on the aetio-pathogenesis of the disease together with inadequate capacity for ... more

Download (302)

View PDF (221)

Tome 5 Caractéristiques des personnes vulnérables au Bénin; Analyses des Résultats

Ministère Chargé du Plan, de La Prospective et du développement ; Institut National de la Statistique et de l’Analyse Economique, République du Bénin (2003) C2

Il n’est de richesse que d’hommes dit-on. En vertu de ce principe, le Gouvernement de la République du Bénin, désireux de connaître et d’apprécier l’importance et la qualité de ses ressources humaines a décidé, par décret n° 99-459 du 22 septembre 1999, d’organiser sur toute l... more

Download (158)

View PDF (216)

Recomendaciones para el tratamiento hospitalario de la COVID-19 en pacientes adultos ( Version 10, 2020)

G, Zambrano, E Salgato, F. M. Moyano et al. (2020) CC

Recommendations for in-patient management of COVID-19 in adult patients Version 10, November 2020.

Download (345)

View PDF (456)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (1584)

View PDF (2723)

The Pediatric Clinical Manual

Elaine Abrams, Wafaa El-Sadr, and Miriam Rabkin The International Center for AIDS Programm (2004)

Download (196)

View PDF (191)

Sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy

World Health Organization WHO (2022) C_WHO

WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resi... more

Download (1284)

View PDF (2147)

Guidelines for the Treatment of Chronic Hepatitis B and C Viral Infections in Kenya
recommended

Prof. G. N. Lule, Dr. B. Nyawira Gastroenterology Society of Kenya , Republic of Keny (2015) C1

Download (320)

View PDF (407)

Lineamientos para el Manejo Clínico y Operativo de la Tuberculosis Drogorresistente

J. A. Caminero, A. Van Deun, P. I. Fujiwara, et. al Unión Internacional Contra la Tuberculosis y Enfermedades Respiratorias (2013)

Download (301)

View PDF (492)

Tuberculosis prevention, care and control A practical directory of new advances

Stop TB Partnership; World Health Organization ; USAID (2011) C_WHO

Management of Diabetes Mellitus-Tuberculosis recommended

One health joint plan of action (‎2022‒2026)‎: working together for the health of humans, animals, plants and the environment recommended

Guidelines for the Treatment of Chronic Hepatitis B and C Viral Infections in Kenya recommended

Management of Diabetes Mellitus-Tuberculosis
recommended

One health joint plan of action (‎2022‒2026)‎: working together for the health of humans, animals, plants and the environment
recommended

Guidelines for the Treatment of Chronic Hepatitis B and C Viral Infections in Kenya
recommended